BioLife Solutions, Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$96M
Cost of Revenue
$34M
Gross Profit
$62M
R&D
$8M
D&A
$2M
Operating Income
$-17M
EBITDA
$-14M
Interest Expense
$3M
Interest Income
—
Other Income/Expense
$7M
Pretax Income
$-12M
Tax Provision
$49K
Net Income
$-5M
Gross Margin
64.6%
Operating Margin
-17.3%
Net Margin
-4.8%
Effective Tax Rate
-0.4%
Deferred Tax Assets
—
Deferred Tax Liabilities
$189K
DTA Valuation Allowance
$51M
Tax Credit Carryforwards
$3M
NOL Carryforwards
$168M
ETR (Continuing Operations)
-0.4%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.7%
ETR Foreign Differential (pp)
-0.3%
Operating Lease Cost
$2M
Revenue YoY Variation
28.9%
Income YoY Variation
-270.8%